Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-06-092665
Filing Date
2006-04-28
Accepted
2006-04-28 14:31:43
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 1391061
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 7340
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 7535
4 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex32.htm EX-32 7168
5 GRAPHIC g72475g81z99.jpg GRAPHIC 65723
  Complete submission text file 0001193125-06-092665.txt   1505223
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12465 | Film No.: 06789088
SIC: 2834 Pharmaceutical Preparations